Aging-associated formaldehyde-induced norepinephrine deficiency contributes to age-related memory decline

Area of Science:

• Neuroscience
• Biochemistry
• Aging Research

Background:

• Norepinephrine (NE) deficiency is linked to cognitive disorders in aging and Alzheimer's disease.
• The endogenous factors driving NE depletion remain largely unknown.

Purpose of the Study:

• To investigate the role of aging-associated formaldehyde (FA) in NE inactivation and cognitive function.
• To explore FA as a potential endogenous factor contributing to age-related cognitive decline.

Main Methods:

• In vitro and in vivo experiments assessing FA's effect on NE.
• Intrahippocampal injections of FA and NE in rodents.
• Behavioral tests for spatial memory and long-term potentiation (LTP) in aging rodent models (SAMP8 and SAMR1 mice).
• Administration of resveratrol as an FA scavenger.

Main Results:

• Age-related DNA demethylation leads to hippocampal FA accumulation and reduced NE levels.
• FA rapidly inactivates NE in vitro and in vivo, mimicking age-related NE deficiency.
• FA or 6-hydroxydopamine (6-OHDA) injections impaired LTP and spatial memory, while NE injections reversed these deficits in aged rats.
• Resveratrol or NE administration restored LTP and memory in senescence-accelerated prone 8 (SAMP8) mice by reducing FA and increasing NE.

Conclusions:

• Accumulated formaldehyde is a critical endogenous factor responsible for aging-associated norepinephrine depletion.
• FA accumulation contributes significantly to cognitive decline and memory deficits during aging.
• Targeting FA accumulation or restoring NE levels may offer therapeutic strategies for age-related cognitive impairment.